Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today launched research-grade ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon ...

-- Launch of End-to-End Workflow for AVITI and AVITI24™ Enabling Sample to Sequencer in as Little as Five Hours -- -- Twist Gains Exclusive Access to the new, co-developed Trinity Freestyle™ ...

"It's kind of a renter’s market right now," Twist CEO Emily Leproust told the Business Times while striking a deal to ...

Twist Bioscience (TWST) just rolled out research grade Plasmid DNA Preps tailored for pre clinical pharma and biotech work, a small but telling move that helps explain the recent uptick in the stock.

Twist Bioscience (NASDAQ:TWST) is gearing up to announce its quarterly earnings on Monday, 2025-05-05. Here's a quick overview of what investors should know before the release. Analysts are estimating ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon ...

Robert W. Baird analyst Catherine Ramsey Schulte maintained a Buy rating on Twist Bioscience (TWST – Research Report) on July 15 and set a price target of $40.00. Catherine Ramsey Schulte’s rating is ...

Twist Bioscience has shown revenue growth from $54.4m in 2019 to potentially >$300m in 2024, but continues to post losses. Despite a diverse customer base and innovative synthetic DNA technology, ...

Fiscal 2025 guidance includes projected revenue growth of 17%-20% and a gross margin target of 48%, improving to 50% by Q4FY25. Twist Bioscience shipped products to approximately 3,562 customers in ...

5 analysts have shared their evaluations of Twist Bioscience (NASDAQ:TWST) during the recent three months, expressing a mix of bullish and bearish perspectives. The following table summarizes their ...

Paula Green, the Senior Vice President of Human Resources at Twist Bioscience Corp (NASDAQ:TWST), recently sold a portion of her holdings in the company. According to a filing with the Securities and ...